OGN Protein (Transcript Variant 3) (Myc-DYKDDDDK Tag)

Produktnummer ABIN2726014

Dieses Recombinant OGN-Protein wird in HEK-293 Cells exprimiert.

Kurzübersicht für OGN Protein (Transcript Variant 3) (Myc-DYKDDDDK Tag) (ABIN2726014)

Target: OGN (Osteoglycin (OGN))

Protein-Typ: Recombinant

Spezies: Human

Quelle: HEK-293 Cells

Applikation: Antibody Production (AbP), Standard (STD)

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Produktdetails

Proteineigenschaft: Transcript Variant 3

Aufreinigungstag / Konjugat: Dieses OGN Protein ist gelabelt mit Myc-DYKDDDDK Tag.

Produktmerkmale:

• Recombinant human Mimecan (transcript variant 3) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the C-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: OGN (Osteoglycin (OGN))

Andere Bezeichnung: Mimecan

Hintergrund: Induces bone formation in conjunction with TGF-beta-1 or TGF-beta-2. [UniProtKB/Swiss-Prot Function]

Molekulargewicht: 31.8 kDa

NCBI Accession: NP_054776

Pathways: Glycosaminoglycan Metabolic Process